Skip to content
MedsAcross

Medicine

Ceftriaxone 1 g powder for injection

Ceftriaxone · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Ceftriaxone 1 g powder for injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from light.

Key facts

Active ingredient (INN)
Ceftriaxone
Brand
Sold under the generic name
Strength
1 g
Dosage form
Powder for injection
Route
Intravenous
Packs
10 vials
Manufacturer
Hospira
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01DD04 Ceftriaxone
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
14 July 2005
Identifiers
RxCUI 1665021, 1665046DailyMed set ID 9d1f630b-e759-4395-9d01-ddc90e4fea75, 128bb292-d174-4769-b3e6-9f16617f31e3NDC 0409-7333Application ANDA065204

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0409-7333-04Hospira20 July 2005
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0409-7333-49Hospira20 July 2005
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0409-7332-01—9 May 2005
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0409-7332-20—19 March 2018
25 vial in 1 carton / 1 injection, powder, for solution in 1 vial44567-701-25—24 July 2008
25 vial in 1 carton / 1 injection, powder, for solution in 1 vial44567-701-95—5 January 2023
1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use60505-6148-0—3 March 2020
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use60505-6148-4—30 June 2017
25 vial in 1 carton / 1 injection, powder, for solution in 1 vial63323-346-10—20 June 2011
25 vial in 1 box / 1 injection, powder, for solution in 1 vial0143-9857-25—10 January 2008
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use67184-1007-1—29 June 2016
25 vial in 1 carton / 1 injection, powder, for solution in 1 vial25021-106-10—5 November 2009
1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0781-3208-85—9 May 2005
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use0781-3208-95—9 May 2005
1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use85766-069-01—1 October 2025
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use85766-069-10—1 October 2025
1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use85766-210-01—23 July 2026
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use85766-210-10—23 July 2026
25 vial in 1 box / 1 injection, powder, for solution in 1 vial72572-061-25—1 March 2020
1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use71205-545-01—11 March 2021
10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use70518-2499-0—19 December 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 December 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ceftriaxone 1 g powder for injection.

Compare 1

Other strengths and forms of Ceftriaxone

Clinical summary

Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of infections when caused by susceptible bacteria, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Ceftriaxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ceftriaxone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ceftriaxone 1 g powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.